A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib

University Hospital of West Attica - Attikon, Chaïdári

Hospital Universitario Virgen de Las Nieves, Granada

Hospital of the University of Pennsylvania, Philadelphia

Temple University Department of Thoracic Medicine and Surgery, Philadelphia

University Medical Centre Hamburg-Eppendorf Centre of Oncology, Hamburg

Hospital Universitario Ramon Y Cajal, Madrid

City of Hope National Medical Center, Duarte

Sarah Cannon Research Institute, Nashville

Cleveland Clinic, Cleveland

Parkview Cancer Institute, Fort Wayne

University Hospital Mannheim, Mannheim

Texas Oncology San Antonio, San Antonio

Anschutz Cancer Pavilion-University of Colorado, Aurora

Aou San Giovanni Di Dio E Ruggi, Salerno

Azienda Ospedaliera Bianchi-Melacrino-Morelli Ospedali Riuniti, Reggio Calabria

Hadassah Hebrew University Medical Center Ein Karem Hadassah, Jerusalem

Azienda Policlinico Vittorio Emanuele, Catania

Ordensklinikum Linz Gmbh Elisabethinen, Linz

Universitaire Ziekenhuis Leuven - Gasthuisberg, Leuven

Providence Health, Vancouver

Universitatsklinikum Halle (Saale), Halle